Active substance : omeprazole
Form : Powder and solvent for solution for injection
Dosage : 40 mg (4 mg/ml after reconstitution with the solvent included)
Packaging : Vial with powder of active substance and solvent ampoule
Target : adults
Adults
Dafrazol® IV is indicated in adults as an alternative to oral therapy
– Treatment and prevention of recurrence of duodenal ulcers / gastric ulcers
– In combination with appropriate antibiotics, eradication of Helicobacter pylori in peptic ulcer disease.
– Treatment of reflux oesophagitis and symptomatic gastro-oesophageal reflux disease / Long-term management of patients recovered from reflux oesophagitis.
– Treatment of Zollinger-Ellison syndrome.
Adults: As an alternative to oral treatment
– In patients for whom the oral route is not appropriate, 40 mg of Dafrazol® IV is recommended once daily.
– In patients with Zollinger-Ellison syndrome, the recommended starting dose of Dafrazol® IV is 60 mg daily.
– Larger daily doses may be required and individual dosage adjustments should be made. If doses are higher than 60 mg per day, the dose should be divided into two daily doses.
Dafrazol® IV powder is reconstituted with Dafrazol® IV solvent into a solution for intravenous injection. After reconstitution, the injection should be given slowly over at least 2 minutes at a maximum rate of 4 ml per minute.
Prescription drugs. Please contact your doctor.
